DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Unveiling the microbiome-mediated potential of a carob-based formulation (Csat®): human fecal fermentation, SCFA production, and potential connections with satiety pathways
Data will be made available on request., Microbial fermentation of dietary fibers produces short-chain fatty acids (SCFAs) that may shape host metabolism and appetite control. Csat®, a standardized carob-based formulation, has shown satiety and metabolic benefits in animal models, but its influence on human gut microbiome remained untested. We therefore incubated human fecal microbiota in anaerobic batch fermentations with Csat®, a seed-derived galactomannan fraction (GM), a carob pulp extract (CPE), or control medium, and profiled bacterial community composition (sequencing of full-length 16S rRNA gene amplicons), predicted functional capacity (PICRUSt2/COG, CAZy), and SCFA output (GC-FID) at 0, 24 and 48 h. Csat® produced the most pronounced fermentation response: across timepoints it generated the highest acetate, propionate and butyrate concentrations while preserving bacterial community balance. Taxonomically, Csat® shifted the microbiota toward carbohydrate-degrading taxa (notably Bacteroides) and canonical butyrogenic genera (Anaerostipes and Blautia), and correlation networks pointed to active cross-feeding between primary degraders and secondary fermenters. Functional inferences mirrored these changes: GM elicited strong extracellular glycosidase signatures consistent with mannan hydrolysis, CPE favored pectin/fructan-targeting functions, and Csat® combined hydrolytic and enhanced sugar-uptake potential (transport ATPases), a combination that plausibly sustains higher SCFA flux. Together, these results show that Csat® can reprogram human-derived microbial communities in vitro to favour SCFA production via complementary hydrolysis and transport processes. The data provide a potential mechanistic bridge between prior in vivo efficacy and the rationale for further clinical studies to test whether microbiome-mediated SCFA increases translate into meaningful hormonal and appetite outcomes in humans., Iván Benito-Vázquez was supported by a predoctoral Industrial Doctorate grant (IND2022/BIO-23522) awarded to the Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC) and Pharmactive Biotech Products S.L.U., and funded by the Comunidad de Madrid. This work was also supported by the Spanish State Research Agency (AEI/MICINN) under grants PID2022-136874OB-C31, PID2024-158847OB-I00 and PREP2022-000376. This work has been supported by the MaX CSIC Excellence Award DEEP-MaX-2024-2_CIAL We thank Elena Berciano Ledesma (Technician Assistant, Unidad de Técnicas Bioanalíticas, CIAL) for technical assistance., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-136874OB-C31
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2024-2027 PID2024-158847OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PREP2022-000376